Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (441-450 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|October 10, 2021
Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysisPaul J Bröckelmann, Horst Müller, Sarah Gillessen, et al.
Leukemia|October 21, 2021
AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcomePeng Li, Thomas White, Wei Xie, et al.
Leukemia|March 24, 2022
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial resultsAlexander Popov, Guenter Henze, Julia Roumiantseva, et al.
Leukemia|April 12, 2022
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Leukemia|April 3, 2022
Identification of a c-MYB-directed therapeutic for acute myeloid leukemiaKatherine Clesham, Vanessa Walf-Vorderwülbecke, Luca Gasparoli, et al.
Leukemia|March 31, 2022
Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspectiveYoshihiro Hayashi, Yuka Harada, Hironori Harada
Leukemia|November 3, 2021
Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemiaArnold Kloos, Konstantinos Mintzas, Lina Winckler, et al.
Leukemia|March 5, 2022
Co-targeting leukemia-initiating cells and leukemia bulk leads to disease eradicationSimona Moretti, Amal Kamal Abdel-Aziz, Elena Ceccacci, et al.
Leukemia|March 5, 2022
Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab eraManette A W Dinnessen, Carolien C H M Maas, Sanne H Tonino, et al.
Leukemia|October 10, 2019
DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myelomaPriya Choudhry, Margarette C Mariano, Huimin Geng, et al.
Pageof 1,398

Showing results (441-450 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|October 10, 2021
Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysisPaul J Bröckelmann, Horst Müller, Sarah Gillessen, et al.
Leukemia|October 21, 2021
AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcomePeng Li, Thomas White, Wei Xie, et al.
Leukemia|March 24, 2022
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial resultsAlexander Popov, Guenter Henze, Julia Roumiantseva, et al.
Leukemia|April 12, 2022
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, et al.
Leukemia|April 3, 2022
Identification of a c-MYB-directed therapeutic for acute myeloid leukemiaKatherine Clesham, Vanessa Walf-Vorderwülbecke, Luca Gasparoli, et al.
Leukemia|March 31, 2022
Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspectiveYoshihiro Hayashi, Yuka Harada, Hironori Harada
Leukemia|November 3, 2021
Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemiaArnold Kloos, Konstantinos Mintzas, Lina Winckler, et al.
Leukemia|March 5, 2022
Co-targeting leukemia-initiating cells and leukemia bulk leads to disease eradicationSimona Moretti, Amal Kamal Abdel-Aziz, Elena Ceccacci, et al.
Leukemia|March 5, 2022
Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab eraManette A W Dinnessen, Carolien C H M Maas, Sanne H Tonino, et al.
Leukemia|October 10, 2019
DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myelomaPriya Choudhry, Margarette C Mariano, Huimin Geng, et al.
Pageof 1,398